Medical/Pharmaceuticals
Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia
SAN FRANCISCO and SUZHOU, China, Jan. 19, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
Oncologist Herbert Loong Joins George Clinical Scientific Leadership
OVERLAND PARK, Kansas, Jan. 18, 2021 /PRNewswire/ -- Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based inHong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research ...
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELPTM platform to develop next-generation gene therapies. This new collaboration combines Boeh...
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
* Rolontis and Oraxol BLA/NDA approval from U.S. FDA is expected within this year * LAPSTriple Agonist, an innovative triple-acting new drug for NASH treatment, indication expansion * Efpeglenatide met the primary endpoint for global Phase 3 * Striving for developing rare diseases such as...
Regent Pacific Group Limited Announces the Successful Launch of Fortacin(TM) in Hong Kong, Upcoming Launches in Taiwan and Macau and Related Business Updates
HONG KONG, Jan. 18, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Fortacin™, the Group's ...
TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases
SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases associated with bacterial infections and dysbioses, announced today that it ...
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that the European Medicines Agency (EMA) has granted PRior...
Everest Medicines Announces Amended Agreement with Spero Therapeutics
SHANGHAI, Jan. 18, 2021 /PRNewswire/ -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts ofAsia, today announced that under an amen...
StarMed Specialist Centre partners Prudential on the PRUPanel Connect Programme to deliver quality private healthcare experience for patients
SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- StarMed Specialist Centre ("StarMed"), a private ambulatory care service provider under the HMI Group, has entered into a partnership with Prudential Singapore ("Prudential") as a preferred specialist healthcare and day surgery partner on the insurer's PRU...
CES 2021 MedFluid Develops First-In-Class Microfluidic Platform for Rapid Detection and Screening of Disease Diagnosis
TAIPEI, Taiwan, Jan. 17, 2021 /PRNewswire/ -- Health and Biotech company
MedFluid has developed the fastest, first-in-class antimicrobial susceptibility
test that will aid in providing precise medical prescriptions to improve the
health and well-being of patients.
COVID-19 vaccines: Common solution, not competition
BEIJING, Jan. 15, 2021 /PRNewswire/ -- A news report by China.org.cn on China's COVID-19 vaccines:   At the end of 2020, one of China's self-developed COVID-19 vaccines was granted conditional approval for general use by the National Medical Products Administration. Previously,...
Senhwa Biosciences Presents Positive Cholangiocarcinoma Data
TAIPEI and SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announces that promising clinical data from their global phase...
Gracell Biotechnologies Receives Medical Products Manufacturing Certificate for CAR-T Cell Therapy Products
SUZHOU, China, Jan. 15, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted the Medical Products Manuf...
Modern Chinese Medicine Group Co., Ltd. Trading Debut Closed at HK$1.26 Per Share
HONG KONG, Jan. 15, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...
CES 2021 Taiwanese Startup ACSI Gives New Technological Shine to Traditional Chinese Medical Treatments
TAIPEI, Jan. 15, 2021 /PRNewswire/ -- Chinese medicine has been receiving increased attention worldwide. These traditional therapeutic treatments are now being combined with modern technology and integrated into Western medicine. Acupuncture, for example, is being widely adopted and trusted by pa...
Hyde Engineering + Consulting Announces Appointment of Chief Executive Officer
Kerren Bergman Promoted to Lead Hyde's Global Corporation BOULDER, Colo., Jan. 15, 2021 /PRNewswire/ -- Hyde Engineering + Consulting, Inc. (Hyde) a worldwide partner for solution-based pharmaceutical design and consulting services, announced the appointment of Kerren Bergman as Chief Executive ...
Nonin Medical Announces New Full Board of Directors
MINNEAPOLIS, Jan. 14, 2021 /PRNewswire/ -- Nonin Medical announced the appointment of four new members to the company's board of directors. Each of the new directors brings unique industry experience and passion for innovation in the medtech and healthcare sectors. Together, they will provide Non...
Huami to Host 2021 Strategy and Outlook Investor Fireside Chat with CEO Wang Huang on January 22
BEIJING, Jan. 14, 2021 /PRNewswire/ -- Huami Corp. (NYSE: HMI) today announced that it will hold a Fireside Chat conference call for investors on Friday,22 January 2021. The company will discuss its 2021 strategies for consumer and industrial health technologies, including its product plans annou...
Modern Chinese Medicine Group Co., Ltd. announces its subscription results
HONG KONG, Jan. 14, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...
Ascentage Pharma Presents Updates on its Global Clinical Development at the J.P. Morgan 39th Annual Healthcare Conference
SUZHOU, China and ROCKVILLE, Md., Jan. 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, presented at the J.P. Morgan 39th Annual Hea...
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 317 media titles]
2024-05-07 08:00VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 312 media titles]
2024-05-08 14:37OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 306 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 290 media titles]
2024-05-08 16:44